SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-008841
Filing Date
2020-07-31
Accepted
2020-07-31 09:00:47
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20200630x10q.htm   iXBRL 10-Q 1317585
2 EX-31.1 glyc-20200630xex31d1.htm EX-31.1 17009
3 EX-31.2 glyc-20200630xex31d2.htm EX-31.2 16830
4 EX-32.1 glyc-20200630xex32d1.htm EX-32.1 9437
  Complete submission text file 0001558370-20-008841.txt   5114083

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20200630.xsd EX-101.SCH 29126
6 EX-101.CAL glyc-20200630_cal.xml EX-101.CAL 37491
7 EX-101.DEF glyc-20200630_def.xml EX-101.DEF 141190
8 EX-101.LAB glyc-20200630_lab.xml EX-101.LAB 282743
9 EX-101.PRE glyc-20200630_pre.xml EX-101.PRE 269168
10 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20200630x10q_htm.xml XML 905358
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 201063866
SIC: 2834 Pharmaceutical Preparations